Sunshine Biopharma (SBFM) Current Assets (2010 - 2026)
Sunshine Biopharma's Current Assets was $30.67 million in Q2 2026, up 10.1% from $27.85 million a year earlier and up 23.7% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Sunshine Biopharma came in at $26.85 million, up 3.4% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 92.1% (FY2020 to FY2025).
- In earlier years, Current Assets was $25.97 million in FY2024 (+4.3%), $24.89 million in FY2023 (-8.9%), $27.31 million in FY2022 and $2.2 million in FY2021 (+114.0%).
- The Q2 2026 figure marks the highest quarterly Current Assets since Q3 2022.
- Compared with a year earlier, Current Assets has increased for five straight quarters, with growth averaging 2.7% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q1 2022 (growth of 627.8%); the worst was Q2 2023 (a decline of 37.8%).
- Per Business Quant data, SBFM's Current Assets in the three quarters before Q2 2026 was $24.78 million (Q1 2026), $26.85 million (Q4 2025) and $27.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Sunshine Biopharma | 1.12 Mn | -37.97 Mn | 2.43 Mn | 30.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.67 Mn |
| Mar 31, 2026 | 24.78 Mn |
| Dec 31, 2025 | 26.85 Mn |
| Sep 30, 2025 | 27.97 Mn |
| Jun 30, 2025 | 27.85 Mn |
| Mar 31, 2025 | 24.48 Mn |
| Dec 31, 2024 | 25.97 Mn |
| Sep 30, 2024 | 25.98 Mn |
| Jun 30, 2024 | 25.75 Mn |
| Mar 31, 2024 | 28.83 Mn |
| Dec 31, 2023 | 24.89 Mn |
| Sep 30, 2023 | 25.43 Mn |
| Jun 30, 2023 | 26.10 Mn |
| Mar 31, 2023 | 24.95 Mn |
| Dec 31, 2022 | 27.31 Mn |
| Sep 30, 2022 | 40.86 Mn |
| Jun 30, 2022 | 41.99 Mn |
| Mar 31, 2022 | 13.41 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 2.49 Mn |
API Access
Sunshine Biopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();